Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Heine Annkristin |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2025
Originalarbeit (Zeitschrift)
** Klesse, M; Schanz, O; Heine, A
Establishing a low-dose x-ray irradiation protocol for experimental acute graft-versus-host disease.
Exp Hematol. 2025; 104765
Doi: 10.1016/j.exphem.2025.104765
Web of Science
PubMed
FullText
FullText_MUG
Kommentar
** Kosiol, N; Heine, A; Brossart, P
Targeting cancer: tumor-specific splicing events give rise to immunogenic, tumor-wide neoantigens.
Signal Transduct Target Ther. 2025; 10(1): 144
Doi: 10.1038/s41392-025-02237-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2024
Originalarbeit (Zeitschrift)
** Heine, A; Lemmermann, NAW; Flores, C; Becker-Gotot, J; Garbi, N; Brossart, P; Kurts, C
Rapid protection against viral infections by chemokine-accelerated post-exposure vaccination.
Front Immunol. 2024; 15: 1338499
Doi: 10.3389/fimmu.2024.1338499
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Orth, HM; Flasshove, C; Berger, M; Hattenhauer, T; Biederbick, KD; Mispelbaum, R; Klein, U; Stemler, J; Fisahn, M; Doleschall, AD; Baermann, BN; Koenigshausen, E; Tselikmann, O; Killer, A; de, Angelis, C; Gliga, S; Stegbauer, J; Spuck, N; Silling, G; Rockstroh, JK; Strassburg, CP; Brossart, P; Panse, JP; Jensen, BO; Luedde, T; Boesecke, C; Heine, A; Cornely, OA; Monin, MB
Early combination therapy of COVID-19 in high-risk patients.
Infection. 2024; 52(3): 877-889.
Doi: 10.1007/s15010-023-02125-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schlaweck, S; Radcke, A; Kampmann, S; Becker, BV; Brossart, P; Heine, A
The Immunomodulatory Effect of Different FLT3 Inhibitors on Dendritic Cells.
Cancers (Basel). 2024; 16(21):
Doi: 10.3390/cancers16213719
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Aderhold, W; Lenz, B; Hübner, MP; Schaefer, HE; Gaertner, FC; Heine, A; Gütgemann, I
Intramedullary leukocytoclastic vasculitis and neutrophil extracellular trap (NET) formation in POEMS syndrome.
Ann Hematol. 2024; 103(4): 1415-1417.
Doi: 10.1007/s00277-024-05651-w
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Brandenburg, A; Heine, A; Brossart, P
Next-generation cancer vaccines and emerging immunotherapy combinations.
Trends Cancer. 2024; 10(8): 749-769.
Doi: 10.1016/j.trecan.2024.06.003
Web of Science
PubMed
FullText
FullText_MUG
** Klein, CR; Heine, A; Brossart, P; Karakostas, P; Schäfer, VS
Anti-MDA5 autoantibodies predict clinical dynamics of dermatomyositis following SARS-CoV-2 mRNA vaccination: a retrospective statistical analysis of case reports.
Rheumatol Int. 2024; 44(10): 2185-2196.
Doi: 10.1007/s00296-024-05683-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fallbericht
** Fetter, T; Fietz, S; Bertlich, M; Braegelmann, C; de, Vos-Hillebrand, L; Wenzel, J; Heine, A; Landsberg, J; Jansen, P
Severe autoimmune hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma: a case report.
Front Immunol. 2024; 15: 1342845
Doi: 10.3389/fimmu.2024.1342845
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Mispelbaum, R; Hattenhauer, T; Bauernfeind, FG; Lau, JF; Brossart, P; Heine, A
Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden.
Front Oncol. 2024; 14:1406616
Doi: 10.3389/fonc.2024.1406616
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schloesser, L; Loeffler, KU; Heine, A; Holz, FG; Herwig-Carl, MC
Dynamics of microcyst-like epithelial changes associated with Belantamab mafodotin therapy in a patient with multiple myeloma-a case report.
Blood Cancer J. 2024; 14(1): 133
Doi: 10.1038/s41408-024-01110-x
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2023
Originalarbeit (Zeitschrift)
** Heine, A; Held, SAE; Daecke, SN; Flores, C; Brossart, P
Spoilt for choice: different immunosuppressive potential of anaplastic lymphoma kinase inhibitors for non small cell lung cancer.
Front Immunol. 2023; 14:1257017
Doi: 10.3389/fimmu.2023.1257017
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Köksal, M; Baumert, J; Jazmati, D; Schoroth, F; Garbe, S; Koch, D; Scafa, D; Sarria, GR; Leitzen, C; Massoth, G; Delis, A; Heine, A; Holderried, T; Brossart, P; Müdder, T; Schmeel, LC
Whole body irradiation with intensity-modulated helical tomotherapy prior to haematopoietic stem cell transplantation: analysis of organs at risk by dose and its effect on blood kinetics.
J Cancer Res Clin Oncol. 2023; 149(10):7007-7015
Doi: 10.1007/s00432-023-04657-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Köksal, M; Kersting, L; Schoroth, F; Garbe, S; Koch, D; Scafa, D; Sarria, GR; Leitzen, C; Heine, A; Holderried, T; Brossart, P; Zoga, E; Attenberger, U; Schmeel, LC
Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy.
J Cancer Res Clin Oncol. 2023; 149(9):5965-5973
Doi: 10.1007/s00432-022-04565-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Köksal, M; Özkan, O; Holderried, T; Heine, A; Brossart, P; Gawish, A; Scafa, D; Sarria, GR; Leitzen, C; Schmeel, LC; Müdder, T
Optimized Conformal Total Body Irradiation with VMAT Using a Linear-Accelerator-Based Radiosurgery Treatment System in Comparison to the Golden Standard Helical TomoTherapy.
Cancers (Basel). 2023; 15(17):
Doi: 10.3390/cancers15174220
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Voigt, MB; Kravchenko, D; Isaak, A; Heine, A; Holderried, TAW; Luetkens, JA
Cardiovascular Magnetic Resonance Assessment of Immunotherapy Cardiotoxicity
CURR CARDIOVASC IMAG. 2023; 16(12): 103-115.
Doi: 10.1007/s12410-023-09584-2
Web of Science
FullText
FullText_MUG
2022
Originalarbeit (Zeitschrift)
** Güresir, Á; Coch, C; Heine, A; Mass, E; Lampmann, T; Vatter, H; Velten, M; Schmitz, MT; Güresir, E; Wach, J
Red Blood Cell Distribution Width to Platelet Count Ratio Facilitates Preoperative Prediction of Recurrence in Surgically Treated Chronic Subdural Hematoma.
Front Neurol. 2022; 13:884231
Doi: 10.3389/fneur.2022.884231
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Klümper, N; Saal, J; Berner, F; Lichtensteiger, C; Wyss, N; Heine, A; Bauernfeind, FG; Ellinger, J; Brossart, P; Diem, S; Schmid, S; Joerger, M; Frueh, M; Ritter, M; Hölzel, M; Flatz, L; Bald, T
C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer.
J Immunother Cancer. 2022; 10(3):
Doi: 10.1136/jitc-2021-004024
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Mispelbaum, R; Hattenhauer, ST; Brossart, P; Heine, A
Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors.
Front Immunol. 2022; 13:976011
Doi: 10.3389/fimmu.2022.976011
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Mispelbaum, R; Hattenhauer, ST; Held, SAE; Brossart, P; Heine, A
Baseline immune signature score of Tregs × HLA-DR+CD4+ T cells × PD1+CD8+ T cells predicts outcome to immunotherapy in cancer patients.
Front Immunol. 2022; 13:1054161
Doi: 10.3389/fimmu.2022.1054161
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Koerber, RM; Held, SAE; Vonnahme, M; Feldmann, G; Wenzel, J; Gütgemann, I; Brossart, P; Heine, A
Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report
J CANCER RES CLIN. 2022; 148(3): 743-748.
Doi: 10.1007/s00432-021-03777-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Monin, MB; Marx, B; Meffert, L; Boesecke, C; Rockstroh, JK; Strassburg, CP; Brossart, P; Heine, A
SARS-CoV-2 PrEP complicates antibody testing after vaccination: a call for awareness.
Ann Hematol. 2022; 101(9):2089-2090
Doi: 10.1007/s00277-022-04859-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schlaweck, S; Brossart, P; Heine, A
Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah's Witness patient
ANN HEMATOL. 2022; 101(1): 217-218.
Doi: 10.1007/s00277-021-04403-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fallbericht
** Saal, J; Aboudan, B; Brossart, P; Heine, A
Two cases of EBV infection preceding lymphoma.
J Cancer Res Clin Oncol. 2022; 148(10):2929-2932
Doi: 10.1007/s00432-022-04145-4
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2021
Originalarbeit (Zeitschrift)
** Braun, C; Schlaweck, S; Daecke, SN; Brossart, P; Heine, A
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells
CANCER IMMUNOL IMMUN. 2021; 70(12): 3693-3700.
Doi: 10.1007/s00262-021-02988-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** De Magis, A; Kastl, M; Brossart, P; Heine, A; Paeschke, K
BG-flow, a new flow cytometry tool for G-quadruplex quantification in fixed cells
BMC BIOL. 2021; 19(1): 45
Doi: 10.1186/s12915-021-00986-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Dold, L; Lutz, P; Heine, A; Weismuller, TJ; Strassburg, CP; Spengler, U
Ruxolitinib for treatment of polycythemia vera and myelofibrosis in patients after liver transplantation
CLIN CASE REP. 2021; 9(9): e04782
Doi: 10.1002/ccr3.4782
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Faron, A; Isaak, A; Mesropyan, N; Reinert, M; Schwab, K; Sirokay, J; Sprinkart, AM; Bauernfeind, FG; Dabir, D; Pieper, CC; Heine, A; Kuetting, D; Attenberger, U; Landsberg, J; Luetkens, JA
Cardiac MRI Depicts Immune Checkpoint Inhibitor-induced Myocarditis: A Prospective Study
RADIOLOGY. 2021; 301(3): 602-609.
Doi: 10.1148/radiol.2021210814
Web of Science
PubMed
FullText
FullText_MUG
** Heine, A; Wolf, AM; Schlaweck, S; Daecke, SN; Brossart, P; Wolf, D
Pacritinib protects dendritic cells more efficiently than ruxolitinib
EXP HEMATOL. 2021; 100: 37-40.
Doi: 10.1016/j.exphem.2021.06.004
Web of Science
PubMed
FullText
FullText_MUG
** Kravchenko, D; Isaak, A; Zimmer, S; Mesropyan, N; Reinert, M; Faron, A; Pieper, CC; Heine, A; Velten, M; Nattermann, J; Kuetting, D; Duerr, GD; Attenberger, U; Luetkens, JA
Cardiac MRI in Patients with Prolonged Cardiorespiratory Symptoms after Mild to Moderate COVID-19
RADIOLOGY. 2021; 301(3): E419-E425.
Doi: 10.1148/radiol.2021211162
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schanz, O; Cornez, I; Yajnanarayana, SP; David, FS; Peer, S; Gruber, T; Krawitz, P; Brossart, P; Heine, A; Landsberg, J; Baier, G; Wolf, D
Tumor rejection in Cblb-/- mice depends on IL-9 and Th9 cells
J IMMUNOTHER CANCER. 2021; 9(7): e002889
Doi: 10.1136/jitc-2021-002889
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Heine, A; Holderried, TAW; Wolf, D
ROCKing Chronic Graft-Versus-Host Disease
J CLIN ONCOL. 2021; 39(29):
Doi: 10.1200/JCO.21.01081
Web of Science
PubMed
FullText
FullText_MUG
** Luetkens, JA; Isaak, A; Öztürk, C; Mesropyan, N; Monin, M; Schlabe, S; Reinert, M; Faron, A; Heine, A; Velten, M; Dabir, D; Boesecke, C; Strassburg, CP; Attenberger, U; Zimmer, S; Duerr, GD; Nattermann, J
Cardiac MRI in Suspected Acute COVID-19 Myocarditis
RADIOL-CARDIOTHORAC. 2021; 3(2): e200628
Doi: 10.1148/ryct.2021200628
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schlaweck, S; Strauss, L; Daecke, S; Brossart, P; Heine, A
Elotuzumab spares dendritic cell integrity and functionality
J CANCER RES CLIN. 2021; 147(7): 2167-2170.
Doi: 10.1007/s00432-021-03572-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Heine, A; Juranek, S; Brossart, P
Clinical and immunological effects of mRNA vaccines in malignant diseases
MOL CANCER. 2021; 20(1): 52
Doi: 10.1186/s12943-021-01339-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kosiol, N; Juranek, S; Brossart, P; Heine, A; Paeschke, K
G-quadruplexes: a promising target for cancer therapy
MOL CANCER. 2021; 20(1): 40
Doi: 10.1186/s12943-021-01328-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Linke, R; Limmer, M; Juranek, SA; Heine, A; Paeschke, K
The Relevance of G-Quadruplexes for DNA Repair
INT J MOL SCI. 2021; 22(22): 12599
Doi: 10.3390/ijms222212599
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2020
Originalarbeit (Zeitschrift)
** Baumann, T; Dunkel, A; Schmid, C; Schmitt, S; Hiltensperger, M; Lohr, K; Laketa, V; Donakonda, S; Ahting, U; Lorenz-Depiereux, B; Heil, JE; Schredelseker, J; Simeoni, L; Fecher, C; Koerber, N; Bauer, T; Hueser, N; Hartmann, D; Laschinger, M; Eyerich, K; Eyerich, S; Anton, M; Streeter, M; Wang, T; Schraven, B; Spiegel, D; Assaad, F; Misgeld, T; Zischka, H; Murray, PJ; Heine, A; Heikenwaelder, M; Korn, T; Dawid, C; Hofmann, T; Knolle, PA; Hoechst, B
Regulatory myeloid cells paralyze T cells through cell-cell transfer of the metabolite methylglyoxal
NAT IMMUNOL. 2020; 21(5): 555-+.
Doi: 10.1038/s41590-020-0666-9
Web of Science
PubMed
FullText
FullText_MUG
** Duerr, GD; Heine, A; Hamiko, M; Zimmer, S; Luetkens, JA; Nattermann, J; Rieke, G; Isaak, A; Jehle, J; Held, SAE; Wasmuth, JC; Wittmann, M; Strassburg, CP; Brossart, P; Coburn, M; Treede, H; Nickenig, G; Kurts, C; Velten, M
Parameters predicting COVID-19-induced myocardial injury and mortality
LIFE SCI. 2020; 260: 118400
Doi: 10.1016/j.lfs.2020.118400
Web of Science
PubMed
FullText
FullText_MUG
Editorial
** Luetkens, JA; Isaak, A; Zimmer, S; Nattermann, J; Sprinkart, AM; Boesecke, C; Rieke, GJ; Zachoval, C; Heine, A; Velten, M; Duerr, GD
Diffuse Myocardial Inflammation in COVID-19 Associated Myocarditis Detected by Multiparametric Cardiac Magnetic Resonance Imaging
CIRC-CARDIOVASC IMAG. 2020; 13(5): e010897
Doi: 10.1161/CIRCIMAGING.120.010897
Web of Science
PubMed
FullText
FullText_MUG
2019
Originalarbeit (Zeitschrift)
** Holderried, TAW; Fraccaroli, A; Schumacher, M; Hein, A; Brossart, P; Stelljes, M; Klobuch, S; Kröger, N; Apostolova, P; Finke, J; Zeiser, R; Heinicke, T; Bornhäuser, M; Von Bergwelt-Baildon, M; Tischer, J; Wolf, D
The role of checkpoint blockade after allogeneic stem cell transplantation in diseases other than Hodgkin's Lymphoma
BONE MARROW TRANSPL. 2019; 54(10): 1662-1667.
Doi: 10.1038/s41409-019-0498-0
Web of Science
PubMed
FullText
FullText_MUG
2018
Originalarbeit (Zeitschrift)
** Schwab, KS; Kristiansen, G; Schild, HH; Held, SEA; Heine, A; Brossart, P
Successful Treatment of Refractory Squamous Cell Cancer of the Head and Neck with Nivolumab and Ipilimumab
CASE REP ONCOL. 2018; 11(1): 17-20.
Doi: 10.1159/000485562
Web of Science
PubMed
FullText
FullText_MUG
2017
Originalarbeit (Zeitschrift)
** Heine, A; Flores, C; Gevensleben, H; Diehl, L; Heikenwalder, M; Ringelhan, M; Janssen, KP; Nitsche, U; Garbi, N; Brossart, P; Knolle, PA; Kurts, C; Höchst, B
Targeting myeloid derived suppressor cells with all-trans retinoic acid is highly time-dependent in therapeutic tumor vaccination
ONCOIMMUNOLOGY. 2017; 6(8): e1338995
Doi: 10.1080/2162402X.2017.1338995
Web of Science
PubMed
FullText
FullText_MUG
** Heine, A; Held, SAE; Schulte-Schrepping, J; Wolff, JFA; Klee, K; Ulas, T; Schmacke, NA; Daecke, SN; Riethausen, K; Schultze, JL; Brossart, P
Generation and functional characterization of MDSC-like cells
ONCOIMMUNOLOGY. 2017; 6(4): e1295203
Doi: 10.1080/2162402X.2017.1295203
Web of Science
PubMed
FullText
FullText_MUG
** Heuser, C; Gotot, J; Piotrowski, EC; Philipp, MS; Courrèges, CJF; Otte, MS; Guo, L; Schmid-Burgk, JL; Hornung, V; Heine, A; Knolle, PA; Garbi, N; Serfling, E; Evaristo, C; Thaiss, F; Kurts, C
Prolonged IKKβ Inhibition Improves Ongoing CTL Antitumor Responses by Incapacitating Regulatory T Cells
CELL REP. 2017; 21(3): 578-586.
Doi: 10.1016/j.celrep.2017.09.082
Web of Science
PubMed
FullText
FullText_MUG
** Kotthoff, P; Heine, A; Held, SAE; Brossart, P
Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways
SCI REP-UK. 2017; 7: 4522
Doi: 10.1038/s41598-017-04558-z
Web of Science
PubMed
FullText
FullText_MUG
2016
Originalarbeit (Zeitschrift)
** Berens, C; Heine, A; Müller, J; Held, SAE; Mayer, K; Brossart, P; Oldenburg, J; Pötzsch, B; Wolf, D; Rühli, H
Variable resistance to freezing and thawing of CD34-positive stem cells and lymphocyte subpopulations in leukapheresis products
CYTOTHERAPY. 2016; 18(10): 1325-1331.
Doi: 10.1016/j.jcyt.2016.06.014
Web of Science
PubMed
FullText
FullText_MUG
** Görtzen, J; Hunka, LM; Vonnahme, M; Praktiknjo, M; Kaifie, A; Fimmers, R; Jansen, C; Heine, A; Lehmann, J; Goethert, JR; Gattermann, N; Goekkurt, E; Platzbecker, U; Brossart, P; Strassburg, CP; Brummendorf, TH; Koschmieder, S; Wolf, D; Trebicka, J
γ-Glutamyl Transferase Is an Independent Biomarker of Splanchnic Thrombosis in Patients With Myeloproliferative Neoplasm
MEDICINE. 2016; 95(20): e3355
Doi: 10.1097/MD.0000000000003355
Web of Science
PubMed
FullText
FullText_MUG
** Heine, A; Schilling, J; Grünwald, B; Krüger, A; Gevensleben, H; Held, SAE; Garbi, N; Kurts, C; Brossart, P; Knolle, P; Diehl, L; Höchst, B
The induction of human myeloid derived suppressor cells through hepatic stellate cells is dose-dependently inhibited by the tyrosine kinase inhibitors nilotinib, dasatinib and sorafenib, but not sunitinib
CANCER IMMUNOL IMMUN. 2016; 65(3): 273-282.
Doi: 10.1007/s00262-015-1790-5
Web of Science
PubMed
FullText
FullText_MUG
** Held, SAE; Heine, A; Kesper, AR; Schönberg, K; Beckers, A; Wolf, D; Brossart, P
Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors
ONCOIMMUNOLOGY. 2016; 5(1): e1065368
Doi: 10.1080/2162402X.2015.1065368
Web of Science
PubMed
FullText
FullText_MUG
** Rittig, SM; Haentschel, M; Weimer, KJ; Heine, A; Müller, MR; Brugger, W; Horger, MS; Maksimovic, O; Stenzl, A; Hoerr, I; Rammensee, HG; Holderried, TA; Kanz, L; Pascolo, S; Brossart, P
Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherapy
ONCOIMMUNOLOGY. 2016; 5(5): e1108511
Doi: 10.1080/2162402X.2015.1108511
Web of Science
PubMed
FullText
FullText_MUG
2015
Originalarbeit (Zeitschrift)
** Heine, A; Held, SAE; Daecke, SN; Riethausen, K; Kotthoff, P; Flores, C; Kurts, C; Brossart, P
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function
PLOS ONE. 2015; 10(6): e0128897
Doi: 10.1371/journal.pone.0128897
Web of Science
PubMed
FullText
FullText_MUG
** Koerber, RM; Held, SAE; Heine, A; Kotthoff, P; Daecke, SN; Bringmann, A; Brossart, P
Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk inhibition in multiple myeloma
EXP HEMATOL ONCOL. 2015; 4: 21
Doi: 10.1186/s40164-015-0016-z
Web of Science
PubMed
FullText
FullText_MUG
** Schönberg, K; Rudolph, J; Vonnahme, M; Yajnanarayana, SP; Cornez, I; Hejazi, M; Manser, AR; Uhrberg, M; Verbeek, W; Koschmieder, S; Brümmendorf, TH; Brossart, P; Heine, A; Wolf, D
JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms
CANCER RES. 2015; 75(11): 2187-2199.
Doi: 10.1158/0008-5472.CAN-14-3198
Web of Science
PubMed
FullText
FullText_MUG
** Yajnanarayana, SP; Stübig, T; Cornez, I; Alchalby, H; Schönberg, K; Rudolph, J; Triviai, I; Wolschke, C; Heine, A; Brossart, P; Kröger, N; Wolf, D
JAK1/2 inhibition impairs T cell function invitro and in patients with myeloproliferative neoplasms
BRIT J HAEMATOL. 2015; 169(6): 824-833.
Doi: 10.1111/bjh.13373
Web of Science
PubMed
FullText
FullText_MUG
Editorial
** Heine, A; Brossart, P
A party of three: iNKT cells in GVHD prevention
BLOOD. 2015; 125(22): 3374-3375.
Doi: 10.1182/blood-2015-04-636282
Web of Science
PubMed
FullText
FullText_MUG
2014
Übersichtsarbeit
** Wolf, D; Heine, A; Brossart, P
Implementing combinatorial immunotherapeutic regimens against cancer The concept of immunological conditioning
ONCOIMMUNOLOGY. 2014; 3(1): e27588
Doi: 10.4161/onci.27588
Web of Science
PubMed
FullText
FullText_MUG
2013
Originalarbeit (Zeitschrift)
** Heine, A; Held, SAE; Daecke, SN; Wallner, S; Yajnanarayana, SP; Kurts, C; Wolf, D; Brossart, P
The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo
BLOOD. 2013; 122(7): 1192-1202.
Doi: 10.1182/blood-2013-03-484642
Web of Science
PubMed
FullText
FullText_MUG
** Heine, A; Schmiedel, A; Menschik, T; Held, SAE; Erdmann, C; Brossart, P
Regression of Liver Metastases After Treatment With Oxaliplatin/Capecitabine and Development of a Progressive Multifocal Leukoencephalopathy in a Patient With Advanced Thymoma
J CLIN ONCOL. 2013; 31(12): E203-E205.
Doi: 10.1200/JCO.2012.43.8150
Web of Science
PubMed
FullText
FullText_MUG
** Held, SAE; Duchardt, KM; Tenzer, S; Rückrich, T; von Schwarzenberg, K; Bringmann, A; Kurts, C; Schild, H; Driessen, C; Brossart, P; Heine, A
Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptides
CANCER IMMUNOL IMMUN. 2013; 62(4): 715-726.
Doi: 10.1007/s00262-012-1373-7
Web of Science
PubMed
FullText
FullText_MUG
** Held, SAE; Heine, A; Mayer, KT; Kapelle, M; Wolf, DGF; Brossart, P
Advances in Immunotherapy of Chronic Myeloid Leukemia CML
CURR CANCER DRUG TAR. 2013; 13(7): 768-774.
Web of Science
PubMed
Kurzbericht/Letter
** Heine, A; Brossart, P; Wolf, D
Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis?
BLOOD. 2013; 122(23): 3843-3844.
Doi: 10.1182/blood-2013-10-531103
Web of Science
PubMed
FullText
FullText_MUG
2011
Originalarbeit (Zeitschrift)
** Kock, G; Bringmann, A; Held, SAE; Daecke, S; Heine, A; Brossart, P
Regulation of dectin-1-mediated dendritic cell activation by peroxisome proliferator-activated receptor-gamma ligand troglitazone
BLOOD. 2011; 117(13): 3569-3574.
Doi: 10.1182/blood-2010-08-302224
Web of Science
PubMed
FullText
FullText_MUG
** Rittig, SM; Haentschel, M; Weimer, KJ; Heine, A; Muller, MR; Brugger, W; Horger, MS; Maksimovic, O; Stenzl, A; Hoerr, I; Rammensee, HG; Holderried, TAW; Kanz, L; Pascolo, S; Brossart, P
Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients
MOL THER. 2011; 19(5): 990-999.
Doi: 10.1038/mt.2010.289
Web of Science
PubMed
FullText
FullText_MUG
2010
Übersichtsarbeit
** Bringmann, A; Held, SAE; Heine, A; Brossart, P
RNA Vaccines in Cancer Treatment
J BIOMED BIOTECHNOL. 2010; 623687
Doi: 10.1155/2010/623687
Web of Science
PubMed
FullText
FullText_MUG
2009
Übersichtsarbeit
** Heine, A; Holderried, TAW; Brossart, P
Immunotherapy in renal cell carcinoma
IMMUNOTHERAPY-UK. 2009; 1(1): 97-107.
Doi: 10.2217/1750743X.1.1.97
Web of Science
PubMed
FullText
FullText_MUG
2008
Originalarbeit (Zeitschrift)
** Grünebach, F; Erndt, S; Häntschel, M; Heine, A; Brossart, P
Generation of antigen-specific CTL responses using RGS1 mRNA transfected dendritic cells
CANCER IMMUNOL IMMUN. 2008; 57(10): 1483-1491.
Doi: 10.1007/s00262-008-0486-5
Web of Science
PubMed
FullText
FullText_MUG
** Yokoyama, Y; Grünebach, F; Schmidt, SM; Heine, A; Häntschel, M; Stevanovic, S; Rammensee, HG; Brossart, P
Matrilysin (MMP-7) is a novel broadly expressed tumor antigen recognized by antigen-specific T cells
CLIN CANCER RES. 2008; 14(17): 5503-5511.
Doi: 10.1158/1078-0432.CCR-07-4041
Web of Science
PubMed
FullText
FullText_MUG
2006
Originalarbeit (Zeitschrift)
** Heine, A; Grünebach, F; Holderried, T; Appel, S; Weck, MM; Dörfel, D; Sinzger, C; Brossart, P
Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses
MOL THER. 2006; 13(2): 280-288.
Doi: 10.1016/j.ymthe.2005.08.019
Web of Science
PubMed
FullText
FullText_MUG
2005
Originalarbeit (Zeitschrift)
** Dörfel, D; Appel, S; Grünebach, F; Weck, MM; Müller, MR; Heine, A; Brossart, P
Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA
BLOOD. 2005; 105(8): 3199-3205.
Doi: 10.1182/blood-2004-09-3556
Web of Science
PubMed
FullText
FullText_MUG